FDA Investigator Andrew B Bevill
Andrew B Bevill has inspections in 1 countries as of 29 Jun 2023. Andrew B Bevill has collaborated with a combined 1085 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
27
Last Inspection Date:
29 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
A Ble Bevill,
Adam C Hipko,
Andrea A Branche,
Ashley N Williams,
Brandi E Williams,
Charles D Brown,
Charles I Ann,
Chmura,
Christopher J Hurst,
Contractor Bridgers,
Cynthia A Harris, MD, RN,
Darla J Christopher,
Debra J Tucker,
Ed Gonzalez Vazquez,
Edmiston,
Edward E Lockwood (EEL),
Elizabeth D Connell,
Ellen J Tave,
Frans E Mercado,
Frederic W French, III,
Grant,
Grant L Davis,
Hung V Le,
James C Warren,
Jamie M Bumpas,
Jamie P Webb,
Janice M Hickok,
Jeffrey C Archer,
Jeffrey R Wooley,
Jocelyn C Turner,
Jose E Melendez, DDC,
Karen C Daugherty,
Kari M Johansen,
Kari M Laynor,
Karlton T Watson,
Kayla V Sprague,
King,
Lance D Johnson,
Lauren E Skokan,
Lisa R Jennings,
Lisa R Whitt,
Lonna M Potter,
Lorie S Hannappel,
Martin K Yau, PhD,
Merelynn Rhoten,
Michael L Jones,
Paula J Perry,
Pauline N Logan,
Payne,
Phillip D Waldron,
Rhonda L Dash,
Ron Mabrysmelz,
Ronald C Mabry Smith,
Sandy J Ziegler,
Sha'tina R Alridge,
Shawn E Larson,
Stephen D Brown,
Toby Vern H Hill,
Tonya R Johnson,
Torrance J Slayton,
Travis S Brown,
Tricia S Martinez,
Tricia Y Samaniego,
Vincent E Litman
Andrew B Bevill's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2000 | EIR | Henry C Farrar, MD - EIR, 2000-01-27 |
January, 2001 | FDA 483 | United Labs, Inc - Form 483, 2001-01-31 |
April, 2001 | FDA 483 | Charles River Laboratories - Form 483, 2001-04-13 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more